Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Int Psychogeriatr ; 33(6): 577-586, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-32431251

RESUMEN

OBJECTIVES: To evaluate the effect of the PROPER intervention in nursing home residents with dementia on the prevalence of psychotropic drug use and neuropsychiatric symptoms. DESIGN: A cluster-randomized controlled design with two parallel groups (intervention versus usual care) and assessments at 0, 6, 12, and 18 months. SETTING: Thirty-one dementia special care units within 13 long-term care organizations in the Netherlands. PARTICIPANTS: Three hundred eighty nursing home residents with dementia. INTERVENTION: The PROPER intervention consisted of a structured and repeated multidisciplinary medication review, supported by education and continuous evaluation. MEASUREMENTS: Prescriptions of antipsychotics, antidepressants, anxiolytics, and hypnotics, and occurrence of neuropsychiatric symptoms. RESULTS: The prescription of any type of psychotropic drugs increased in the intervention group, and decreased in the control group, with an estimated difference of 3.9 percentage points per 6 months (p = 0.01). Effects for the individual drug groups were minor (differences of 1.6 percentage points and below per 6 months) and not statistically significant. The occurrence of neuropsychiatric symptoms remained stable in both the intervention and control groups during the follow-up of 18 months. CONCLUSIONS: The PROPER intervention failed to demonstrate effectiveness in reducing the prevalence of psychotropic drugs. It may be interesting to enrich the intervention with components that address personal attitudes and communication between nursing home professionals, not only with respect to the prescription of psychotropic drugs, but also to neuropsychiatric symptoms.The study has been registered in The Netherlands Trial Register (NTR3569).


Asunto(s)
Antipsicóticos/uso terapéutico , Demencia/tratamiento farmacológico , Prescripciones de Medicamentos/estadística & datos numéricos , Psicotrópicos/uso terapéutico , Anciano , Anciano de 80 o más Años , Femenino , Hogares para Ancianos , Humanos , Masculino , Persona de Mediana Edad , Casas de Salud , Psicofarmacología , Resultado del Tratamiento
2.
Int Psychogeriatr ; 30(3): 437-446, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-28595662

RESUMEN

ABSTRACTBackground:Both neuropsychiatric symptoms (NPS) and psychotropic drug use (PDU) are common in institutionalized People with Young Onset Dementia (PwYOD) and can produce negative outcomes such as reduced quality of life and high workload. In community-dwelling PwYOD, NPS are found to be associated with unmet care needs. This emphasizes the importance of a care program for the management of NPS in institutionalized PwYOD that also addresses unmet care needs and PDU. The objectives of the Behavior and Evolution of Young ONset Dementia part 2 (BEYOND-II) study are to develop a care program for the management of NPS in institutionalized PwYOD and to evaluate its effectiveness. METHODS: The care program consists of an educational program combined with an intervention to manage NPS with the following five steps: the evaluation of psychotropic drug prescription, detection, analysis (including the detection of unmet needs), treatment and the evaluation of NPS. A stepped wedge design will be used to evaluate its effectiveness. The primary outcomes are agitation and aggression and other NPS. The secondary outcomes are PDU, quality of life, the workload of nursing staff and job satisfaction. Additionally, a process analysis and a cost-consequence analysis will be conducted. CONCLUSIONS: The study protocol of the Beyond-II study describes the development, implementation and evaluation of a care program for the management of NPS in institutionalized PwYOD. This care program provides a structured method for the management of NPS, in which unmet needs and PDU are also addressed.


Asunto(s)
Edad de Inicio , Demencia/tratamiento farmacológico , Casas de Salud/estadística & datos numéricos , Agitación Psicomotora/tratamiento farmacológico , Psicotrópicos/uso terapéutico , Anciano , Demencia/diagnóstico , Demencia/psicología , Prescripciones de Medicamentos , Femenino , Humanos , Vida Independiente , Institucionalización , Masculino , Escalas de Valoración Psiquiátrica , Agitación Psicomotora/diagnóstico , Agitación Psicomotora/psicología , Calidad de Vida
3.
Aging Ment Health ; 22(4): 468-473, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-28290708

RESUMEN

OBJECTIVES: Receiving a timely and accurate diagnosis and gaining access to age-appropriate support for younger people living with dementia (YPD) remains a challenge both in the UK and internationally because the focus of most dementia services is primarily upon the needs of older people. The political case to improve services for YPD depends upon the establishment of an understanding of the clinical symptoms, an unequivocal evidence base about need and an accurate evaluation of the size of the population affected. This short report assesses the evidence base from international studies regarding service design and delivery. The goal is to raise awareness, advance best practice and galvanise the international community to address the serious underfunding and underprovision of care for this marginalised group. CONCLUSION: The current evidence suggests that there are universal problems, regardless of continent, with delays to diagnosis and poor understanding of optimum models for service provision and long-term care.


Asunto(s)
Demencia/diagnóstico , Demencia/epidemiología , Demencia/terapia , Necesidades y Demandas de Servicios de Salud , Calidad de la Atención de Salud , Edad de Inicio , Diagnóstico Tardío , Europa (Continente)/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad
4.
Int Nurs Rev ; 63(3): 507-16, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27374988

RESUMEN

AIM: Provide insight into the concept of stress in the context of challenging behaviour of nursing home residents with dementia and its causes and consequences. BACKGROUND: Challenging behaviour is frequent in residents with dementia, but consequences for nursing staff are unclear. INTRODUCTION: Challenging behaviour of residents can be enervating for nurses and may lead to stress. Although stress in general is associated with negative outcomes, an overview of stress in this context would be a welcome addition to the field. METHOD: Concept analysis according to Walker and Avant. RESULTS: Identified antecedents of stress: physical and verbal aggression, conflicts, excessive demands and being unresponsive (residents), age, experience, tenure, nursing level and training (nursing staff). Defining attributes: disturbed homoeostasis and the personal appraisal of the situation. Identified consequences regard health, psychological aspects and behaviour. DISCUSSION: Intervening in the identified factors may contribute to prevention of stress in nursing staff. LIMITATIONS: Given a lack of strong empirical studies, our analysis is not based on a high level of evidence and needs to be tested. Papers from before 1990 might have been missed. CONCLUSION: The concept analysis revealed that nursing staff stress in the context of challenging behaviour may result from resident and nursing staff factors. Besides health and psychological consequences, behavioural consequences can enormously impact the well-being of residents. IMPLICATIONS: Application in daily care to support teams in influencing resident and nursing staff factors could prevent stress, for instance using behavioural management training or recruiting higher educated nursing staff. Given the increasing complexity of care, creating specialized units with specifically trained staff for different groups of people with dementia may be desirable.


Asunto(s)
Demencia/enfermería , Anciano , Anciano de 80 o más Años , Humanos , Casas de Salud , Personal de Enfermería , Médicos
5.
Eur J Neurol ; 21(11): 1361-8, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25039901

RESUMEN

One of the worst outcomes of acquired brain injury is the vegetative state, recently renamed 'unresponsive wakefulness syndrome' (VS/UWS). A patient in VS/UWS shows reflexive behaviour such as spontaneous eye opening and breathing, but no signs of awareness of the self or the environment. We performed a systematic review of VS/UWS prevalence studies and assessed their reliability. Medline, Embase, the Cochrane Library, CINAHL and PsycINFO were searched in April 2013 for cross-sectional point or period prevalence studies explicitly stating the prevalence of VS/UWS due to acute causes within the general population. We additionally checked bibliographies and consulted experts in the field to obtain 'grey data' like government reports. Relevant publications underwent quality assessment and data-extraction. We retrieved 1032 papers out of which 14 met the inclusion criteria. Prevalence figures varied from 0.2 to 6.1 VS/UWS patients per 100 000 members of the population. However, the publications' methodological quality differed substantially, in particular with regards to inclusion criteria and diagnosis verification. The reliability of VS/UWS prevalence figures is poor. Methodological flaws in available prevalence studies, the fact that 5/14 of the studies predate the identification of the minimally conscious state (MCS) as a distinct entity in 2002, and insufficient verification of included cases may lead to both overestimation and underestimation of the actual number of patients in VS/UWS.


Asunto(s)
Estado Vegetativo Persistente/epidemiología , Prevalencia , Humanos
6.
Int Psychogeriatr ; 26(12): 1973-81, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-25295790

RESUMEN

BACKGROUND: People with Young Onset Dementia (YOD) have specific needs for care. These people eventually require institutional care, usually delivered by institutions designed for the elderly. The Dutch network of care organizations delivering specialized YOD care offers a unique opportunity to obtain more knowledge of this special population. METHODS: Our cross-sectional study collected data from 230 people with YOD in eight care homes providing YOD specialized care. Data collected: demographic data, disease duration, dementia subtype, comorbidity, dementia severity (Global Deterioration Scale - GDS), neuropsychiatric symptoms (NPS; Neuropsychiatric Inventory - NPI, Cohen Mansfield Agitation Inventory - CMAI), disease awareness (Guidelines for the Rating of Awareness Deficits - GRAD), need for assistance (hierarchic Activities of Daily Living (ADL) scale - Resident Assessment Instrument - Minimum Data Set (RAI-MDS)). RESULTS: The mean age of the residents with YOD in care homes was 60 years and 53% of them were men. There is a large variety of etiologic diagnoses underlying the dementia. Dementia severity was very mild to mild in 18%, moderate in 25%, and severe or very severe in 58% of the participants. The prevalence of NPS was high with 90% exhibiting one or more clinically relevant NPS. Comorbidity was present in more than three quarters of the participants, most frequently psychiatric disorders. CONCLUSIONS: The institutionalized YOD population is heterogeneous. NPS occur in almost all institutionalized people with YOD, and frequency and severity of NPS are higher than in late onset dementia (LOD) and community-dwelling YOD patients. Care should be delivered in settings accommodating a mixed male and female population, with appropriate, meaningful activities for all individuals. Further research is needed on NPS in YOD, to enhance quality of life and work in specialized YOD-care.


Asunto(s)
Demencia , Casas de Salud/estadística & datos numéricos , Calidad de Vida , Actividades Cotidianas , Edad de Inicio , Estudios Transversales , Demencia/diagnóstico , Demencia/epidemiología , Demencia/etiología , Demencia/psicología , Demencia/terapia , Progresión de la Enfermedad , Femenino , Humanos , Institucionalización/organización & administración , Masculino , Persona de Mediana Edad , Evaluación de Necesidades , Países Bajos/epidemiología , Prevalencia , Escalas de Valoración Psiquiátrica , Agitación Psicomotora/diagnóstico , Agitación Psicomotora/etiología , Índice de Severidad de la Enfermedad
7.
Int Psychogeriatr ; 26(12): 2023-6, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24831931

RESUMEN

A problematic and disturbing behavior which can develop in people with dementia, is vocally disruptive behavior (VDB). To date, the study of VDB is underdeveloped and with only a limited knowledge base. Medications commonly used in VDB have limited benefits and specific risks in patients with dementia. This report details the case of a patient with frontotemporal dementia with VDB, which responded very well by providing a lollipop. Subsequently, we pose theory-based hypotheses in order to try to explain the beneficial effect of this intervention. This may contribute to a better understanding of VDB and possible treatment strategies.


Asunto(s)
Dulces , Terapias Complementarias/métodos , Demencia Frontotemporal , Conducta Verbal , Síntomas Conductuales/diagnóstico , Síntomas Conductuales/terapia , Demencia Frontotemporal/diagnóstico , Demencia Frontotemporal/psicología , Demencia Frontotemporal/terapia , Humanos , Pruebas de Inteligencia , Relaciones Interpersonales , Masculino , Persona de Mediana Edad , Tomografía de Emisión de Positrones/métodos , Agitación Psicomotora/terapia , Resultado del Tratamiento
8.
Aging Ment Health ; 18(7): 828-32, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24506695

RESUMEN

OBJECTIVES: To assess the differences in antipsychotic drug prescription rates in residents with dementia in dementia special care units (SCUs) of Dutch nursing homes, considering the differences in patient characteristics. METHOD: As part of the Waalbed-II study, the data on antipsychotic drug use in 290 patients were collected and the Global Deterioration Scale (GDS) stage, type of dementia and behaviour (Cohen-Mansfield Agitation Inventory (CMAI)) were measured in 14 SCUs in nine nursing homes. A multilevel logistic regression model was used to assess the difference in antipsychotic drug prescription rates between dementia SCUs adjusted for age, gender, GDS stage, type of dementia and CMAI factor scores. RESULTS: Two hundred and ninety residents met the inclusion criteria. Thirty-two per cent were prescribed an antipsychotic drug. Antipsychotic drugs were more often prescribed in patients with physically aggressive and non-aggressive behaviour and in patients with mixed dementia (vascular/Alzheimer's) than in patients with other types of dementia. Antipsychotic drug prescriptions significantly differed among the dementia SCUs. The odds of antipsychotic drug use for patients in the SCU with the highest prevalence of drug use were 2.76 (95% confidence interval (CI) 1.14-6.69) times as high as for the SCU with the lowest prevalence of drug use, taking the patient characteristics into account. CONCLUSION: Antipsychotic drug use in nursing home residents with dementia is not only predicted by the type of dementia and patient behaviour, but it is independently associated with the dementia SCU at which the patient resides. This result indicates that antipsychotic drugs are not only prescribed for their clinical indications (agitation/aggression) but are associated with environmental factors that may reflect a specific nursing home prescribing culture.


Asunto(s)
Antipsicóticos/uso terapéutico , Demencia/tratamiento farmacológico , Prescripciones de Medicamentos/estadística & datos numéricos , Hospitales Especializados/estadística & datos numéricos , Casas de Salud/estadística & datos numéricos , Anciano , Anciano de 80 o más Años , Demencia/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Países Bajos/epidemiología
9.
Tijdschr Gerontol Geriatr ; 45(3): 144-53, 2014 Jun.
Artículo en Holandés | MEDLINE | ID: mdl-24801121

RESUMEN

INTRODUCTION: Stroke is a frequent and potential invalidating disease, of which recovery can be improved by rehabilitation. In The Netherlands old and frail stroke patients are rehabilitated in nursing homes. Probably, the intensity of and motivation for physiotherapy are important for successful discharge. The aim was to determine (1) therapy intensity of and motivation for physical therapy of geriatric stroke patients (2) its correlates and (3) the effect on discharge destination. METHODS: Data were obtained from the 'GRAMPS'-study, a longitudinal observational study of stroke rehabilitation in 15 Dutch nursing homes. Direct time spent on physiotherapy was registered during admission. Motivation was measured by the Pittsburgh Rehabilitation Participation Scale (PRPS). Data of 84 patients were analysed using uni- and multivariate regression analysis. RESULTS: Patients received an average 109 min of physiotherapy per week. 69 patients (82%) were good motivated for physiotherapy (had all PRPS scores 4 or higher). Therapy intensity was positively associated with the presence of a partner and good motivation. No significant independent variables of motivation were found. Therapy-intensity was positively related to discharge to prior living situation. CONCLUSION: Intensity of physiotherapy of stroke rehabilitation is an independent variable of successful discharge and is higher when the patient has a partner or is better motivated. These findings stress the importance of high motivation and therapy intensity in geriatric stroke rehabilitation.


Asunto(s)
Hogares para Ancianos , Motivación , Casas de Salud , Modalidades de Fisioterapia , Rehabilitación de Accidente Cerebrovascular , Anciano , Anciano de 80 o más Años , Femenino , Anciano Frágil , Humanos , Masculino , Persona de Mediana Edad , Países Bajos , Modalidades de Fisioterapia/psicología , Resultado del Tratamiento
10.
Psychol Med ; 43(2): 423-32, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22640548

RESUMEN

BACKGROUND: The extent to which specific factors influence diagnostic delays in dementia is unclear. Therefore, the aim of the present study was to compare duration from symptom onset to diagnosis for young-onset dementia (YOD) and late-onset dementia (LOD) and to assess the effect of age at onset, type of dementia, gender, living situation, education and family history of dementia on this duration. METHOD: Data on 235 YOD and 167 LOD patients collected from caregivers from two prospective cohort studies were used. Multiple linear regression analysis was performed. RESULTS: The duration between symptom onset and the diagnosis of YOD exceeded that of LOD by an average of 1.6 years (2.8 v. 4.4 years). Young age and being diagnosed with frontotemporal dementia were related to increases in the time to diagnosis. Subjects with vascular dementia experienced shorter time to diagnosis. CONCLUSIONS: There is a need to raise special awareness of YOD to facilitate a timely diagnosis.


Asunto(s)
Actitud Frente a la Salud , Cuidadores/psicología , Diagnóstico Tardío/estadística & datos numéricos , Demencia/diagnóstico , Factores de Edad , Edad de Inicio , Anciano , Demencia/epidemiología , Demencia/genética , Salud de la Familia , Femenino , Predisposición Genética a la Enfermedad , Humanos , Masculino , Persona de Mediana Edad , Países Bajos/epidemiología , Estudios Prospectivos , Análisis de Regresión , Índice de Severidad de la Enfermedad
11.
Tijdschr Gerontol Geriatr ; 43(2): 98-102, 2012 Apr.
Artículo en Holandés | MEDLINE | ID: mdl-22642050

RESUMEN

In this case-report we present a patient with a psychiatric history of a chronic depressive disorder. After a period of several years of ambivalence, he decided to refuse nutrition and hydration because he--in the words of the Royal Dutch Medical Association--was "suffering from life". There was no request for euthanasia or physician assisted suicide. His first attempt, that lasted six weeks, did not result in his death. A second attempt, four months later, ended successfully. We describe the pitfalls that the patient, his family and the professional caregivers faced in both trajectories. The premorbid psychiatric disorder with polypharmacy and several psychotropic drugs as a result, the enormous complaints of thirst, the role of his wife and the dilemmas faced by the professionals made this case very complex. These issues make such cases very challenging for professional teams that have to provide good palliative care.


Asunto(s)
Trastorno Depresivo Mayor/psicología , Ética Médica , Familia/psicología , Grupo de Atención al Paciente/ética , Negativa del Paciente al Tratamiento , Anciano , Actitud Frente a la Muerte , Deshidratación , Resultado Fatal , Humanos , Masculino , Psiquiatría/ética , Psiquiatría/normas , Inanición
12.
Int Psychogeriatr ; 23(8): 1249-59, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21682938

RESUMEN

BACKGROUND: The goal of this study is to determine patterns of psychotropic drug use (PDU), the association with neuropsychiatric symptoms (NPS), and the variability across dementia types in nursing home residents with dementia. In addition, PDU was analyzed across multiple indications. METHODS: This was a prospective cohort study over a two-year period from 2006 to 2008, which involved 14 dementia special care units in nine nursing homes. A total of 117 residents with dementia participated in the study, of whom 35% had Alzheimer's dementia (AD) and 11% vascular dementia (VaD). PDU was classified according to anatomical therapeutic chemical-classification as either "present" or "absent". RESULTS: The majority of residents had moderately severe to severe dementia. At all successive assessments, almost two-thirds of residents received any psychotropic drug (PD) and almost one-third continued to receive any PD. Of all PDs, antipsychotics (APs) were prescribed most frequently. Fewer residents started with antidepressants, but continued to receive antidepressants at higher percentages. Anxiolytics showed an intermittent course, but a subgroup of 9% showed two-year continuation. Once started on PDs at baseline, residents continued to use PDs at high percentages: three-quarters continued to receive APs for at least six months. Half of residents received at least one PD; one-fifth received at least two PDs simultaneously. Residents with AD received more hypnotics and antidementia drugs; residents with VaD received more antipsychotics, antidepressants, anxiolytics and anticonvulsants. CONCLUSIONS: PDs have different utilization patterns, but overall, consistently high continuation rates were found. These results warrant scrutiny of continuous PDU.


Asunto(s)
Demencia/tratamiento farmacológico , Hogares para Ancianos/estadística & datos numéricos , Casas de Salud/estadística & datos numéricos , Pautas de la Práctica en Medicina/estadística & datos numéricos , Psicotrópicos/uso terapéutico , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/tratamiento farmacológico , Ansiolíticos/uso terapéutico , Antidepresivos/uso terapéutico , Antipsicóticos/uso terapéutico , Demencia Vascular/tratamiento farmacológico , Femenino , Humanos , Hipnóticos y Sedantes/uso terapéutico , Masculino , Memoria Episódica , Países Bajos , Índice de Severidad de la Enfermedad
13.
Dement Geriatr Cogn Disord ; 29(3): 189-97, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20215750

RESUMEN

AIMS: The goal of this study is to assess the relationship between quality of life (QoL), neuropsychiatric symptoms (NPS), psychotropic drug use (PDU) and patient characteristics in a large group of nursing home residents with dementia. METHODS: This cross-sectional observational study included 288 individuals with dementia who reside in 14 special care units in 9 nursing homes. The following measures were used: the Qualidem scale to assess QoL, the Neuropsychiatric Inventory-Nursing Home version, the Global Deterioration Scale (GDS), the Severe Impairment Battery-short version, an Activities of Daily Living scale and PDU. Associations between QoL and NPS were examined using multivariate linear regression models with corrections for potential covariates. RESULTS: The average age of the residents was 84 years (SD = +/-7). Agitation, depression, psychosis, psychomotor agitation and psychotropic drugs were independently associated with poor QoL. In patients with mild to moderately severe dementia (GDS 4-6), NPS, PDU and cognitive impairment explained almost half of the variance in QoL scores. Agitation and depression were particularly strong predictors of poor QoL. In patients with severe dementia (GDS 7), agitation, depression, psychosis and cognitive impairment were associated with poor QoL. CONCLUSIONS: NPS, cognition and PDU independently impair QoL for patients in both the moderate and advanced stages of dementia. These results challenge existing pharmacological intervention strategies and highlight the need for psychosocial interventions in the treatment of NPS.


Asunto(s)
Demencia/psicología , Casas de Salud , Calidad de Vida , Actividades Cotidianas , Factores de Edad , Anciano , Anciano de 80 o más Años , Estudios Transversales , Interpretación Estadística de Datos , Utilización de Medicamentos , Femenino , Humanos , Tiempo de Internación , Masculino , Estado Civil , Persona de Mediana Edad , Pruebas Neuropsicológicas , Escalas de Valoración Psiquiátrica , Agitación Psicomotora/complicaciones , Agitación Psicomotora/psicología , Psicotrópicos/uso terapéutico , Análisis de Regresión , Factores Sexuales
14.
J Neurol Neurosurg Psychiatry ; 80(9): 954-9, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19465416

RESUMEN

BACKGROUND: Efficient neuropsychological tests are needed to measure cognitive impairment in moderate to severe dementia. OBJECTIVE: To examine construct validity of the Severe Impairment Battery Short Version (SIB-S) in nursing home patients with moderate to severe dementia, and to examine potential floor effects for the SIB-S. METHODS: Cross-sectional comparison of cognitive measures, dementia severity and functional dependency. RESULTS: A total of 290 patients were included 264 of whom had complete SIB-S protocols. Internal consistency of the SIB-S was very high (Cronbach alpha = 0.97). Principal-component analysis produced three factors, the first of which explained more than 50% of common score variance. Semantic memory items loaded highly on the first factor. Total SIB-S scores were associated with cognitive impairment (SIB-S--Mini Mental State Examination (MMSE) rho = 0.91, p<0.001), and with functional dependency (SIB-S--ADL scale rho = -0.61, p<0.001). SIB-S total scores differentiated between dementia stages as measured with the Global Deterioration Scale (F = 164.6; df 3,260, p<0.001). Comparisons of SIB-S total score variance across patients with moderate to severe dementia and patients with below or above average Mini Mental State Exam scores indicate an absence of large floor effects. CONCLUSION: In this first study examining an independently administered SIB-S, the scale proved to be a homogeneous and valid measure of cognitive impairment. The SIB short version can be used to assess moderately to severely demented patients, who may find it difficult to complete traditional, lengthier neuropsychological tests.


Asunto(s)
Trastornos del Conocimiento/diagnóstico , Trastornos del Conocimiento/psicología , Demencia/diagnóstico , Demencia/psicología , Pruebas Neuropsicológicas , Anciano , Anciano de 80 o más Años , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Países Bajos , Análisis de Componente Principal , Reproducibilidad de los Resultados , Factores Socioeconómicos
15.
J Nutr Health Aging ; 12(2): 145-50, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18264643

RESUMEN

BACKGROUND: Disease management of dementia in general practice (GP) is hampered by a lack of data on the prognosis of dementia. AIM: To gain more insight into the life expectancy of and the effects of cardiovascular and cerebrovascular co-morbidity in dementia patients in GP. DESIGN OF STUDY: Historical cohort. SETTING: 4 general practices in Nijmegen, The Netherlands. POPULATION: All patients in these practices participating in the Continuous Morbidity Registration (CMR). METHODS: The patient cohort was diagnosed with dementia between January 1st 1985 and December 31st 2002. The control cohort consisted of patients matched one-to-one with demented patients on age, sex, and socio-economic status. Cardiovascular and cerebrovascular co-morbidity was studied from 5 years before the diagnosis of dementia till the endpoints of data collection. RESULTS: 251 couples of patients and controls were formed (79 men, 172 women, mean age 81.4+/-7.0 years). The median life expectancy after diagnosis was 2.3 years for the dementia patients, and 3.7 years for the controls. Median time from diagnosis till nursing home placement was 1.4 years. Cerebrovascular and cardiovascular morbidity preceding dementia diagnosis decreased survival of cases with dementia with a relative risk of 1.54 (95%CI: 1.13-2.09) and in controls with a relative risk of 1.91 (95%CI: 1.48-2.46). Obesity was associated with a lower risk of dementia (RR=0.77 (95%-CI 0.63-0.94)). Hypertension and obesity diagnosed after the dementia diagnosis were significantly associated with an increase in survival. CONCLUSION: In general practice, the diagnosis of dementia is made at a late stage, when patients will continue to live at home only for a short time. Moreover, life expectancy at diagnosis is very limited and prognosis is furthermore negatively influenced by preceding cardio- and cerebrovascular co-morbidity.


Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Trastornos Cerebrovasculares/epidemiología , Demencia/epidemiología , Demencia/mortalidad , Medicina Familiar y Comunitaria , Casas de Salud/estadística & datos numéricos , Anciano , Anciano de 80 o más Años , Enfermedades Cardiovasculares/mortalidad , Enfermedades Cardiovasculares/patología , Trastornos Cerebrovasculares/mortalidad , Trastornos Cerebrovasculares/patología , Estudios de Cohortes , Comorbilidad , Demencia/patología , Femenino , Humanos , Esperanza de Vida , Masculino , Países Bajos/epidemiología , Pronóstico , Factores de Riesgo , Clase Social , Análisis de Supervivencia , Factores de Tiempo
16.
J Clin Epidemiol ; 101: 17-27, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-29782995

RESUMEN

OBJECTIVES: Postulating that efficacy of antipsychotics for agitation and psychosis in dementia is best estimated in trials among patients with these symptoms and with symptom-specific outcomes, we investigated whether clinically broader definitions affected the pooled efficacy. STUDY DESIGN AND SETTING: Trials were searched in multiple databases and categorized according to patient population (agitated, psychotic, and mixed) and outcome scale (agitation, psychosis, and generic). Standardized mean differences with 95% confidence intervals were calculated for conventional and atypical antipsychotics separately. RESULTS: Thirty trials met our inclusion criteria. Conventional antipsychotics might have a small effect in agitated patients on agitation scales (-0.44, -0.88, 0.01) and in psychotic patients on psychosis scales (-0.31, -0.61, -0.02). There was no effect on generic scales. Efficacy of atypical antipsychotics was not established in agitated patients on agitation scales (-0.15, -0.43, 0.13) and in psychotic patients on psychosis scales (-0.11, -0.20, -0.03) but was small in mixed patients on agitation scales (-0.29, -0.40, -0.18). CONCLUSION: Pooled efficacy of antipsychotics for agitation and psychosis in dementia is biased when based on trials that included patients without these target symptoms or on results measured with generic scales. This finding is important for reviewers and guideline developers who select trials for reviews.


Asunto(s)
Antipsicóticos/uso terapéutico , Demencia/psicología , Agitación Psicomotora/tratamiento farmacológico , Trastornos Psicóticos/tratamiento farmacológico , Ensayos Clínicos como Asunto , Demencia/tratamiento farmacológico , Humanos , Escalas de Valoración Psiquiátrica , Agitación Psicomotora/etiología , Trastornos Psicóticos/etiología , Resultado del Tratamiento
17.
Tijdschr Gerontol Geriatr ; 38(6): 270-3, 2007 Dec.
Artículo en Holandés | MEDLINE | ID: mdl-18225709

RESUMEN

In 1993 Ribbe en Hertogh published a paper in which they expressed their concern about the high prevalence of psychotropic drug use in Dutch nursing homes. Since then, this situation does not seem to have been changed significantly. Recent figures from psychotropic drug use in patients with dementia show prevalence rates of over 60%. The Dutch government decided to choose the prevalence of psychotropic drug use as an indicator of the quality of care and invested in a specific improvement project that aims to reduce psychotropic drug use among nursing home patients. There is a small body of evidence from international research that antipsychotics safely can be reduced without a rise in problem behaviours. In combination with the limited effectiveness and the risk of stroke and increased mortality, the question raises whether these agents should be prescribed at all at least for patients with dementia. A recent study from the UK however, found a significant decrease of antipsychotic drug use by heavily investing in all kinds of person-centered care skills of the nursing staff. These findings underscore the necessity of investing in the caregivers of nursing homes to be able to cope with the complex problems they are faced with.


Asunto(s)
Antipsicóticos/administración & dosificación , Utilización de Medicamentos/estadística & datos numéricos , Hogares para Ancianos , Casas de Salud , Calidad de la Atención de Salud , Anciano , Anciano de 80 o más Años , Demencia/complicaciones , Demencia/tratamiento farmacológico , Utilización de Medicamentos/tendencias , Femenino , Hogares para Ancianos/normas , Humanos , Masculino , Países Bajos , Casas de Salud/normas
18.
Tijdschr Gerontol Geriatr ; 37(1): 19-24, 2006 Mar.
Artículo en Holandés | MEDLINE | ID: mdl-16529151

RESUMEN

Behavioural problems in dementia are a burden for patients and caregivers and are often the main reason for admission to a nursing home. Research on the prevalence of behavioural problems is scarce. In this study the prevalence of behavioural problems was estimated in nursing home patients with dementia. In 59 demented patients the Neuropsychiatric Inventory (NPI-NH) and the Cohen-Mansfield Agitation Inventory were used to measure behavioural problems over the last two weeks. Behavioural problems were present in about 85% of the study group. Using the NPI-NH aggression/agitation and apathy were present in almost 40% of the patients. Delusions, hallucinations, depression and anxiety were present in 10-15% of the patients. Using the CMAI cursing/verbal aggression, restlessness, complaining, negativism, and mannerisms were prevalent in 30%-50% of the patients. Larger studies on the prevalence of problem behaviour and possibly influencing factors are necessary.


Asunto(s)
Conducta , Demencia/complicaciones , Evaluación Geriátrica/métodos , Hogares para Ancianos , Casas de Salud , Anciano , Anciano de 80 o más Años , Agresión/psicología , Demencia/epidemiología , Demencia/psicología , Femenino , Humanos , Masculino , Trastornos Mentales/complicaciones , Trastornos Mentales/epidemiología , Trastornos Mentales/psicología , Persona de Mediana Edad , Pruebas Neuropsicológicas , Prevalencia , Agitación Psicomotora/epidemiología
19.
Ned Tijdschr Geneeskd ; 150(30): 1653-6, 2006 Jul 29.
Artículo en Holandés | MEDLINE | ID: mdl-16922349

RESUMEN

The number of people suffering from dementia in The Netherlands is expected to rise from 175,000 in 2006 to 400,000 by the year 2050. Stella Braam recently wrote a book in which she described the experiences of her father, a former psychologist with the attitudes and knowledge of professionals concerning communication and coping with dementia, when he became dement himself. She reports that hardly anyone actually listened to the emotions and wishes of her father. Coping with dementia constitutes a major challenge to society. A working-group of the Dutch Institute for Healthcare Improvement CBO recently advised psychological approaches as the first-line treatment for the neuropsychiatric symptoms of dementia; however, they decided not to give concrete guidelines because of the lack of evidence. A study of the literature reveals that the effects of psychosocial interventions are certainly promising even though the evidence is weak. Investment in more research in this field and immediate implementation of the existing knowledge by caregivers and professional workers are recommended.


Asunto(s)
Terapia Cognitivo-Conductual , Demencia/psicología , Demencia/terapia , Psicoterapia , Cuidadores , Medicina Basada en la Evidencia , Humanos
20.
Ned Tijdschr Geneeskd ; 150(28): 1565-73, 2006 Jul 15.
Artículo en Holandés | MEDLINE | ID: mdl-16886695

RESUMEN

OBJECTIVE: To assess the efficacy and adverse reactions of typical and atypical antipsychotics in the treatment of neuropsychiatric symptoms in dementia, and to examine the evidence for the cerebrovascular events warning for atypical antipsychotics. DESIGN: Systematic review. METHOD: Using Medline, Cinahl, PsyclNFO, Embase and the Cochrane central register of controlled trials (1980-2005), double-blind randomized controlled trials with intention-to-treat analysis were selected, which evaluated efficacy and adverse reactions of antipsychotics in the treatment of neuropsychiatric symptoms in dementia. The studies underwent a standardised validity assessment. RESULTS: After screening 950 studies, 14 studies on the effect of haloperidol, risperidone, olanzapine, quetiapine, tiapride, loxapine and perphenazine were selected. In 7 out of 10 studies, haloperidol, risperidone and olanzapine appeared to be more effective than placebo in the treatment of aggression and psychosis. Direct comparison between typical and atypical antipsychotics revealed no statistically significant difference. The most common adverse reactions were extrapyramidal symptoms and somnolence. These adverse reactions were less frequent with low-dose risperidone than with haloperidol or olanzapine, but risperidone and olanzapine were found to be associated with a higher risk of cerebrovascular events in two studies. CONCLUSION: The efficacy of typical and atypical antipsychotics is comparable, but only low-dose risperidone seems to be associated with fewer (extrapyramidal) side effects. The adverse reactions are inadequately described in the published data and consequently the warning of an increased risk of mortality could not be confirmed.


Asunto(s)
Antipsicóticos/efectos adversos , Antipsicóticos/uso terapéutico , Demencia/psicología , Trastornos Psicóticos/tratamiento farmacológico , Agresión/efectos de los fármacos , Agresión/psicología , Benzodiazepinas/efectos adversos , Benzodiazepinas/uso terapéutico , Demencia/complicaciones , Demencia/tratamiento farmacológico , Haloperidol/efectos adversos , Haloperidol/uso terapéutico , Humanos , Olanzapina , Risperidona/efectos adversos , Risperidona/uso terapéutico , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA